On December 6, the Food and Drug Administration (FDA) published a framework for its Real-World Evidence (RWE) Program to strategically leverage information gathered from real-world data (RWD): data that relates to patient health status and/or the delivery of health care routinely collected from a variety of sources.
Please see full publication below for more information.